JPRN-UMIN000011103已完成未知
The investigation of the tolerability and the cost, due to the drug change to novel oral anticoagurants (rivaroxaban) from warfarin in patients with nonvalvular atrial fibrillation in the perioperative period - The investigation of the tolerability and the cost, due to the drug change to novel oral anticoagurants (rivaroxaban) from warfarin in patients with nonvalvular atrial fibrillation in the perioperative period
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)The patients with contraindication of Xarelto 2)The patients who are not allowed to participate in the trial by the principal investigator
研究者
相似试验
进行中（未招募）
1 期
An open-label investigation into the tolerability and pharmacokinetic / pharmacodynamic effects of sufugolix (TAK-013), at a dosage of 100mg twice-daily, during six months treatment of pre-menopausal women with endometriosis.symptomatic endometriosisMedDRA version: 7Level: LLTClassification code 10014778EUCTR2004-003829-28-GBTakeda Europe R&D Centre Ltd
进行中（未招募）
不适用
An open-label investigation into the tolerability and pharmacokinetic / pharmacodynamic effects of sufugolix (TAK-013), at a dosage of 100mg twice-daily, during six months treatment of pre-menopausal women with endometriosis.symptomatic endometriosisMedDRA version: 7Level: LLTClassification code 10014778EUCTR2004-003829-28-DETakeda Europe R&D Centre Ltd20
进行中（未招募）
不适用
An Evaluation of the Tolerability and Feasibility of combining 5-Amino-Levulinic Acid (5-ALA) with Carmustine Wafers (Gliadel) in the Surgical Management of Primary Glioblastoma (GALA-5 Trial) - Feasibility of 5-ALA and Carmustine wafers for Glioblastoma (GALA-5)Primary glioblastomaMedDRA version: 14.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-022496-66-GBJoint UCLH and UCL Biomedical Research Unit
进行中（未招募）
1 期
Cysteamine in Cystic FibrosisCystic FibrosisEUCTR2014-000284-40-GBniversity of Aberdeen12
进行中（未招募）
不适用
Evaluation de la tolérance et de l’acceptabilité de la Rasagiline dans le traitement de la maladie de Parkinson au stade précoce - ACTORMaladie de Parkinson idiopathique au stade précoceMaladie de Parkinson, numéro de classification MedDRA 10061536EUCTR2007-007397-28-FRQualissima